Testicular germ-cell tumours in a broader perspective View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2005-03

AUTHORS

J. Wolter Oosterhuis, Leendert H. J. Looijenga

ABSTRACT

Key PointsGerm-cell tumours (GCTs) of all anatomical sites can be classified into five groups, characterized by their chromosomal complement and developmental potential.The most significant recurrent chromosomal aberrations in type I yolk-sac tumours are loss of 1p, 4 and 6q, and gain of 1q, 12(p13) and 20q. In type II seminomas and non-seminomatous GCTs, the most significant recurrent chromosomal aberrations are gain of 7, 8, 12p, 21 and X, and loss of chromosomes 1p, 11, 13 and 18. Aberrations of 12p are the only recurrent structural abnormalities in type II GCTs. In type III spermatocytic seminomas, gain of chromosome 9 is most common.The originating cell is most probably a primitive germ cell of which the developmental potential differs according to its stage of maturation and pattern of genomic imprinting.Animal models are available for the different groups of GCTs, except for the type II seminomas and non-seminomatous GCTs.An activating KIT mutation in codon 816 is an early pathogenetic event in bilateral testicular seminomas and non-seminomatous GCTs.The transcription factor OCT3/4, a characteristic of primordial germ cells and pluripotent stem cells, is a new and robust diagnostic marker for type II seminomas and non-seminomatous GCTs, including their intratubular precursor.Treatment sensitivity and resistance of GCTs probably correlates with retention and loss of embryonic characteristics (in particular, DNA-repair deficiency), respectively. More... »

PAGES

210-222

References to SciGraph publications

  • 2003-07. Curing metastatic cancer: lessons from testicular germ-cell tumours in NATURE REVIEWS CANCER
  • 2002-11-28. Characteristic promoter hypermethylation signatures in male germ cell tumors in MOLECULAR CANCER
  • 2003-05-14. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary in JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
  • 2003-10-01. Xeroderma Pigmentosum Group A Protein and Chemotherapy Resistance in Human Germ Cell Tumors in LABORATORY INVESTIGATION
  • 2001-07-01. Reactivity of Germ Cell Maturation Stage-Specific Markers in Spermatocytic Seminoma: Diagnostic and Etiological Implications in LABORATORY INVESTIGATION
  • 2000-04. Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells in NATURE GENETICS
  • 1997-05-08. Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard in ONCOGENE
  • 1998-05-21. Identification of the critical region of 12p over-representation in testicular germ cell tumors of adolescents and adults in ONCOGENE
  • 2001-11. Reprogramming of genome function through epigenetic inheritance in NATURE
  • 2002-02-01. VASA Is a Specific Marker for Both Normal and Malignant Human Germ Cells in LABORATORY INVESTIGATION
  • 2000-11-30. Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas in ONCOGENE
  • 2000-07-01. Comparative Genomic and In Situ Hybridization of Germ Cell Tumors of the Infantile Testis in LABORATORY INVESTIGATION
  • 2003-05. What good is genomic imprinting: the function of parent-specific gene expression in NATURE REVIEWS GENETICS
  • 2003-03-27. Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2–p12.1 in ONCOGENE
  • 2003-01-22. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours in ONCOGENE
  • 1997-01-09. Unique expression patterns of H19 in human testicular cancers of different etiology in ONCOGENE
  • 2000-02. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours in NATURE GENETICS
  • 1998-01. Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change in BRITISH JOURNAL OF CANCER
  • 2003-11-11. Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours – a retrospective long-term follow-up study in BRITISH JOURNAL OF CANCER
  • 1998-03. Differential effects of all-trans-retinoic acid, docosahexaenoic acid, and hexadecylphosphocholine on cisplatin-induced cytotoxicity and apoptosis in a cisplantin-sensitive and resistant human embryonal carcinoma cell line in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2002-02-12. Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [18F]FDG PET in BRITISH JOURNAL OF CANCER
  • 2000-08-24. Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis in ONCOGENE
  • 2003-12-07. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells in NATURE BIOTECHNOLOGY
  • 2003-10-23. 12p-Amplicon structure analysis in testicular germ cell tumors of adolescents and adults by array CGH in ONCOGENE
  • 1988-02. The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring in BRITISH JOURNAL OF CANCER
  • 2003-06-17. Aneuploidy of human testicular germ cell tumors is associated with amplification of centrosomes in ONCOGENE
  • 2004-10-18. Defining minimum genomic regions of imbalance involved in testicular germ cell tumors of adolescents and adults through genome wide microarray analysis of cDNA clones in ONCOGENE
  • 2002-05-28. Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors in ONCOGENE
  • 2001-07-17. Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults in BRITISH JOURNAL OF CANCER
  • 2002-12-12. Frequent promoter hypermethylation of the O6-Methylguanine-DNAMethyltransferase (MGMT) gene in testicular cancer in ONCOGENE
  • 2004-10-05. Development of spontaneous tumours and intestinal lesions in Fhit gene knockout mice in BRITISH JOURNAL OF CANCER
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/nrc1568

    DOI

    http://dx.doi.org/10.1038/nrc1568

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1016002664

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/15738984


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Chromosome Aberrations", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Mutational Analysis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Germ Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasms, Germ Cell and Embryonal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prognosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Proto-Oncogene Proteins c-kit", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Seminoma", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Testicular Neoplasms", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Daniel den Hoed Cancer Center, Josephine Nefkens Institute, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands", 
              "id": "http://www.grid.ac/institutes/grid.5645.2", 
              "name": [
                "Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Daniel den Hoed Cancer Center, Josephine Nefkens Institute, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Oosterhuis", 
            "givenName": "J. Wolter", 
            "id": "sg:person.01125770570.54", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125770570.54"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Daniel den Hoed Cancer Center, Josephine Nefkens Institute, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands", 
              "id": "http://www.grid.ac/institutes/grid.5645.2", 
              "name": [
                "Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Daniel den Hoed Cancer Center, Josephine Nefkens Institute, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Looijenga", 
            "givenName": "Leendert H. J.", 
            "id": "sg:person.010444747757.52", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010444747757.52"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nbt922", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005956847", 
              "https://doi.org/10.1038/nbt922"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002800050769", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036230371", 
              "https://doi.org/10.1007/s002800050769"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1206119", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043490334", 
              "https://doi.org/10.1038/sj.onc.1206119"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/labinvest.3780408", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001846975", 
              "https://doi.org/10.1038/labinvest.3780408"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1205488", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013844073", 
              "https://doi.org/10.1038/sj.onc.1205488"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.1988.46", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040974987", 
              "https://doi.org/10.1038/bjc.1988.46"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1200802", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040179514", 
              "https://doi.org/10.1038/sj.onc.1200802"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6602182", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052982902", 
              "https://doi.org/10.1038/sj.bjc.6602182"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1203950", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1032566096", 
              "https://doi.org/10.1038/sj.onc.1203950"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6601383", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009220854", 
              "https://doi.org/10.1038/sj.bjc.6601383"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1186/1476-4598-1-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017552858", 
              "https://doi.org/10.1186/1476-4598-1-8"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00432-003-0437-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1075286638", 
              "https://doi.org/10.1007/s00432-003-0437-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/72877", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1029928219", 
              "https://doi.org/10.1038/72877"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1054/bjoc.2001.1889", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1008663212", 
              "https://doi.org/10.1054/bjoc.2001.1889"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1206469", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024057380", 
              "https://doi.org/10.1038/sj.onc.1206469"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1207011", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028522211", 
              "https://doi.org/10.1038/sj.onc.1207011"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1203769", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041493903", 
              "https://doi.org/10.1038/sj.onc.1203769"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1206302", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033549934", 
              "https://doi.org/10.1038/sj.onc.1206302"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/bjc.1998.47", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052960832", 
              "https://doi.org/10.1038/bjc.1998.47"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc1120", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006850577", 
              "https://doi.org/10.1038/nrc1120"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/labinvest.3780110", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035322820", 
              "https://doi.org/10.1038/labinvest.3780110"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1205978", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040511970", 
              "https://doi.org/10.1038/sj.onc.1205978"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/35102186", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045019773", 
              "https://doi.org/10.1038/35102186"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1201787", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021169319", 
              "https://doi.org/10.1038/sj.onc.1201787"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1208115", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019011958", 
              "https://doi.org/10.1038/sj.onc.1208115"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/labinvest.3780302", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040149918", 
              "https://doi.org/10.1038/labinvest.3780302"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrg1062", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025064233", 
              "https://doi.org/10.1038/nrg1062"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.onc.1201052", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001501834", 
              "https://doi.org/10.1038/sj.onc.1201052"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1097/01.lab.0000090221.95883.41", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014386694", 
              "https://doi.org/10.1097/01.lab.0000090221.95883.41"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6600122", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012978727", 
              "https://doi.org/10.1038/sj.bjc.6600122"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/74199", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018147371", 
              "https://doi.org/10.1038/74199"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2005-03", 
        "datePublishedReg": "2005-03-01", 
        "description": "Key PointsGerm-cell tumours (GCTs) of all anatomical sites can be classified into five groups, characterized by their chromosomal complement and developmental potential.The most significant recurrent chromosomal aberrations in type I yolk-sac tumours are loss of 1p, 4 and 6q, and gain of 1q, 12(p13) and 20q. In type II seminomas and non-seminomatous GCTs, the most significant recurrent chromosomal aberrations are gain of 7, 8, 12p, 21 and X, and loss of chromosomes 1p, 11, 13 and 18. Aberrations of 12p are the only recurrent structural abnormalities in type II GCTs. In type III spermatocytic seminomas, gain of chromosome 9 is most common.The originating cell is most probably a primitive germ cell of which the developmental potential differs according to its stage of maturation and pattern of genomic imprinting.Animal models are available for the different groups of GCTs, except for the type II seminomas and non-seminomatous GCTs.An activating KIT mutation in codon 816 is an early pathogenetic event in bilateral testicular seminomas and non-seminomatous GCTs.The transcription factor OCT3/4, a characteristic of primordial germ cells and pluripotent stem cells, is a new and robust diagnostic marker for type II seminomas and non-seminomatous GCTs, including their intratubular precursor.Treatment sensitivity and resistance of GCTs probably correlates with retention and loss of embryonic characteristics (in particular, DNA-repair deficiency), respectively.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/nrc1568", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1029716", 
            "issn": [
              "1474-175X", 
              "1474-1768"
            ], 
            "name": "Nature Reviews Cancer", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "3", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "5"
          }
        ], 
        "keywords": [
          "non-seminomatous GCTs", 
          "recurrent chromosomal aberrations", 
          "testicular germ cell tumors", 
          "germ cells", 
          "germ cell tumors", 
          "yolk sac tumor", 
          "chromosomal aberrations", 
          "early pathogenetic event", 
          "primitive germ cells", 
          "transcription factor Oct3/4", 
          "primordial germ cells", 
          "bilateral testicular seminoma", 
          "pluripotent stem cells", 
          "testicular seminoma", 
          "robust diagnostic markers", 
          "spermatocytic seminoma", 
          "genomic imprinting", 
          "recurrent structural abnormalities", 
          "anatomical sites", 
          "animal models", 
          "pathogenetic events", 
          "seminoma", 
          "KIT mutations", 
          "structural abnormalities", 
          "stages of maturation", 
          "treatment sensitivity", 
          "diagnostic marker", 
          "codon 816", 
          "tumors", 
          "chromosome 9", 
          "factors Oct3/4", 
          "GCT", 
          "chromosomal complement", 
          "embryonic characteristics", 
          "developmental potential", 
          "stem cells", 
          "chromosome 1p", 
          "cells", 
          "aberrations", 
          "group", 
          "potential differs", 
          "abnormalities", 
          "different groups", 
          "loss", 
          "markers", 
          "mutations", 
          "imprinting", 
          "maturation", 
          "gain", 
          "sites", 
          "sensitivity", 
          "events", 
          "complement", 
          "resistance", 
          "differs", 
          "characteristics", 
          "precursors", 
          "stage", 
          "patterns", 
          "retention", 
          "potential", 
          "broader perspective", 
          "model", 
          "perspective"
        ], 
        "name": "Testicular germ-cell tumours in a broader perspective", 
        "pagination": "210-222", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1016002664"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/nrc1568"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "15738984"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/nrc1568", 
          "https://app.dimensions.ai/details/publication/pub.1016002664"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-11-24T20:52", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_399.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/nrc1568"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nrc1568'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nrc1568'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nrc1568'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nrc1568'


     

    This table displays all metadata directly associated to this object as RDF triples.

    292 TRIPLES      21 PREDICATES      130 URIs      92 LITERALS      17 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/nrc1568 schema:about N013cd534853041329d0336d9e174c7af
    2 N02328d7849434237aed464140f08d49d
    3 N05bbc2999a3d4faf90cb9c8dc751fc1e
    4 N62eafe97d70147f6875ed48cbf5ef805
    5 N6fee59980e844a13b4e0d07b27cc7d03
    6 N85e8b2b845074505a76e6a46196e5eb2
    7 Na8c6a7a07849426ab2028ed299e2263c
    8 Ndf5db6ebaf684e42a79dea14ba45bf35
    9 Ne3641341b93e48329c787a358f6fccbd
    10 Ne721263a63164f7bacc16eef2854262c
    11 anzsrc-for:11
    12 schema:author N65b74e7e73eb4e50a801d4a368195d52
    13 schema:citation sg:pub.10.1007/s002800050769
    14 sg:pub.10.1007/s00432-003-0437-7
    15 sg:pub.10.1038/35102186
    16 sg:pub.10.1038/72877
    17 sg:pub.10.1038/74199
    18 sg:pub.10.1038/bjc.1988.46
    19 sg:pub.10.1038/bjc.1998.47
    20 sg:pub.10.1038/labinvest.3780110
    21 sg:pub.10.1038/labinvest.3780302
    22 sg:pub.10.1038/labinvest.3780408
    23 sg:pub.10.1038/nbt922
    24 sg:pub.10.1038/nrc1120
    25 sg:pub.10.1038/nrg1062
    26 sg:pub.10.1038/sj.bjc.6600122
    27 sg:pub.10.1038/sj.bjc.6601383
    28 sg:pub.10.1038/sj.bjc.6602182
    29 sg:pub.10.1038/sj.onc.1200802
    30 sg:pub.10.1038/sj.onc.1201052
    31 sg:pub.10.1038/sj.onc.1201787
    32 sg:pub.10.1038/sj.onc.1203769
    33 sg:pub.10.1038/sj.onc.1203950
    34 sg:pub.10.1038/sj.onc.1205488
    35 sg:pub.10.1038/sj.onc.1205978
    36 sg:pub.10.1038/sj.onc.1206119
    37 sg:pub.10.1038/sj.onc.1206302
    38 sg:pub.10.1038/sj.onc.1206469
    39 sg:pub.10.1038/sj.onc.1207011
    40 sg:pub.10.1038/sj.onc.1208115
    41 sg:pub.10.1054/bjoc.2001.1889
    42 sg:pub.10.1097/01.lab.0000090221.95883.41
    43 sg:pub.10.1186/1476-4598-1-8
    44 schema:datePublished 2005-03
    45 schema:datePublishedReg 2005-03-01
    46 schema:description Key PointsGerm-cell tumours (GCTs) of all anatomical sites can be classified into five groups, characterized by their chromosomal complement and developmental potential.The most significant recurrent chromosomal aberrations in type I yolk-sac tumours are loss of 1p, 4 and 6q, and gain of 1q, 12(p13) and 20q. In type II seminomas and non-seminomatous GCTs, the most significant recurrent chromosomal aberrations are gain of 7, 8, 12p, 21 and X, and loss of chromosomes 1p, 11, 13 and 18. Aberrations of 12p are the only recurrent structural abnormalities in type II GCTs. In type III spermatocytic seminomas, gain of chromosome 9 is most common.The originating cell is most probably a primitive germ cell of which the developmental potential differs according to its stage of maturation and pattern of genomic imprinting.Animal models are available for the different groups of GCTs, except for the type II seminomas and non-seminomatous GCTs.An activating KIT mutation in codon 816 is an early pathogenetic event in bilateral testicular seminomas and non-seminomatous GCTs.The transcription factor OCT3/4, a characteristic of primordial germ cells and pluripotent stem cells, is a new and robust diagnostic marker for type II seminomas and non-seminomatous GCTs, including their intratubular precursor.Treatment sensitivity and resistance of GCTs probably correlates with retention and loss of embryonic characteristics (in particular, DNA-repair deficiency), respectively.
    47 schema:genre article
    48 schema:isAccessibleForFree false
    49 schema:isPartOf N9230e6cc481f42c4b90fc930efa299d8
    50 Nfe6b2863003c49bc99be8f68ad150b9d
    51 sg:journal.1029716
    52 schema:keywords GCT
    53 KIT mutations
    54 aberrations
    55 abnormalities
    56 anatomical sites
    57 animal models
    58 bilateral testicular seminoma
    59 broader perspective
    60 cells
    61 characteristics
    62 chromosomal aberrations
    63 chromosomal complement
    64 chromosome 1p
    65 chromosome 9
    66 codon 816
    67 complement
    68 developmental potential
    69 diagnostic marker
    70 different groups
    71 differs
    72 early pathogenetic event
    73 embryonic characteristics
    74 events
    75 factors Oct3/4
    76 gain
    77 genomic imprinting
    78 germ cell tumors
    79 germ cells
    80 group
    81 imprinting
    82 loss
    83 markers
    84 maturation
    85 model
    86 mutations
    87 non-seminomatous GCTs
    88 pathogenetic events
    89 patterns
    90 perspective
    91 pluripotent stem cells
    92 potential
    93 potential differs
    94 precursors
    95 primitive germ cells
    96 primordial germ cells
    97 recurrent chromosomal aberrations
    98 recurrent structural abnormalities
    99 resistance
    100 retention
    101 robust diagnostic markers
    102 seminoma
    103 sensitivity
    104 sites
    105 spermatocytic seminoma
    106 stage
    107 stages of maturation
    108 stem cells
    109 structural abnormalities
    110 testicular germ cell tumors
    111 testicular seminoma
    112 transcription factor Oct3/4
    113 treatment sensitivity
    114 tumors
    115 yolk sac tumor
    116 schema:name Testicular germ-cell tumours in a broader perspective
    117 schema:pagination 210-222
    118 schema:productId N5ece66b1544840bf82ca89187e060eae
    119 Na12c78b238404dbe841320841c836115
    120 Nc1515f81190f4a27bc0683a2f9c00eda
    121 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016002664
    122 https://doi.org/10.1038/nrc1568
    123 schema:sdDatePublished 2022-11-24T20:52
    124 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    125 schema:sdPublisher N445e9dbf3820440fbfae35a201d2dfa9
    126 schema:url https://doi.org/10.1038/nrc1568
    127 sgo:license sg:explorer/license/
    128 sgo:sdDataset articles
    129 rdf:type schema:ScholarlyArticle
    130 N013cd534853041329d0336d9e174c7af schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Testicular Neoplasms
    132 rdf:type schema:DefinedTerm
    133 N02328d7849434237aed464140f08d49d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name DNA Mutational Analysis
    135 rdf:type schema:DefinedTerm
    136 N05bbc2999a3d4faf90cb9c8dc751fc1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Prognosis
    138 rdf:type schema:DefinedTerm
    139 N24876c1247514ad08e74cfa4cdf35e41 rdf:first sg:person.010444747757.52
    140 rdf:rest rdf:nil
    141 N445e9dbf3820440fbfae35a201d2dfa9 schema:name Springer Nature - SN SciGraph project
    142 rdf:type schema:Organization
    143 N5ece66b1544840bf82ca89187e060eae schema:name dimensions_id
    144 schema:value pub.1016002664
    145 rdf:type schema:PropertyValue
    146 N62eafe97d70147f6875ed48cbf5ef805 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Neoplasms, Germ Cell and Embryonal
    148 rdf:type schema:DefinedTerm
    149 N65b74e7e73eb4e50a801d4a368195d52 rdf:first sg:person.01125770570.54
    150 rdf:rest N24876c1247514ad08e74cfa4cdf35e41
    151 N6fee59980e844a13b4e0d07b27cc7d03 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Seminoma
    153 rdf:type schema:DefinedTerm
    154 N85e8b2b845074505a76e6a46196e5eb2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Male
    156 rdf:type schema:DefinedTerm
    157 N9230e6cc481f42c4b90fc930efa299d8 schema:volumeNumber 5
    158 rdf:type schema:PublicationVolume
    159 Na12c78b238404dbe841320841c836115 schema:name doi
    160 schema:value 10.1038/nrc1568
    161 rdf:type schema:PropertyValue
    162 Na8c6a7a07849426ab2028ed299e2263c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Germ Cells
    164 rdf:type schema:DefinedTerm
    165 Nc1515f81190f4a27bc0683a2f9c00eda schema:name pubmed_id
    166 schema:value 15738984
    167 rdf:type schema:PropertyValue
    168 Ndf5db6ebaf684e42a79dea14ba45bf35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Chromosome Aberrations
    170 rdf:type schema:DefinedTerm
    171 Ne3641341b93e48329c787a358f6fccbd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    172 schema:name Humans
    173 rdf:type schema:DefinedTerm
    174 Ne721263a63164f7bacc16eef2854262c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Proto-Oncogene Proteins c-kit
    176 rdf:type schema:DefinedTerm
    177 Nfe6b2863003c49bc99be8f68ad150b9d schema:issueNumber 3
    178 rdf:type schema:PublicationIssue
    179 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    180 schema:name Medical and Health Sciences
    181 rdf:type schema:DefinedTerm
    182 sg:journal.1029716 schema:issn 1474-175X
    183 1474-1768
    184 schema:name Nature Reviews Cancer
    185 schema:publisher Springer Nature
    186 rdf:type schema:Periodical
    187 sg:person.010444747757.52 schema:affiliation grid-institutes:grid.5645.2
    188 schema:familyName Looijenga
    189 schema:givenName Leendert H. J.
    190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010444747757.52
    191 rdf:type schema:Person
    192 sg:person.01125770570.54 schema:affiliation grid-institutes:grid.5645.2
    193 schema:familyName Oosterhuis
    194 schema:givenName J. Wolter
    195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01125770570.54
    196 rdf:type schema:Person
    197 sg:pub.10.1007/s002800050769 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036230371
    198 https://doi.org/10.1007/s002800050769
    199 rdf:type schema:CreativeWork
    200 sg:pub.10.1007/s00432-003-0437-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075286638
    201 https://doi.org/10.1007/s00432-003-0437-7
    202 rdf:type schema:CreativeWork
    203 sg:pub.10.1038/35102186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045019773
    204 https://doi.org/10.1038/35102186
    205 rdf:type schema:CreativeWork
    206 sg:pub.10.1038/72877 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029928219
    207 https://doi.org/10.1038/72877
    208 rdf:type schema:CreativeWork
    209 sg:pub.10.1038/74199 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018147371
    210 https://doi.org/10.1038/74199
    211 rdf:type schema:CreativeWork
    212 sg:pub.10.1038/bjc.1988.46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040974987
    213 https://doi.org/10.1038/bjc.1988.46
    214 rdf:type schema:CreativeWork
    215 sg:pub.10.1038/bjc.1998.47 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052960832
    216 https://doi.org/10.1038/bjc.1998.47
    217 rdf:type schema:CreativeWork
    218 sg:pub.10.1038/labinvest.3780110 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035322820
    219 https://doi.org/10.1038/labinvest.3780110
    220 rdf:type schema:CreativeWork
    221 sg:pub.10.1038/labinvest.3780302 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040149918
    222 https://doi.org/10.1038/labinvest.3780302
    223 rdf:type schema:CreativeWork
    224 sg:pub.10.1038/labinvest.3780408 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001846975
    225 https://doi.org/10.1038/labinvest.3780408
    226 rdf:type schema:CreativeWork
    227 sg:pub.10.1038/nbt922 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005956847
    228 https://doi.org/10.1038/nbt922
    229 rdf:type schema:CreativeWork
    230 sg:pub.10.1038/nrc1120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006850577
    231 https://doi.org/10.1038/nrc1120
    232 rdf:type schema:CreativeWork
    233 sg:pub.10.1038/nrg1062 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025064233
    234 https://doi.org/10.1038/nrg1062
    235 rdf:type schema:CreativeWork
    236 sg:pub.10.1038/sj.bjc.6600122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012978727
    237 https://doi.org/10.1038/sj.bjc.6600122
    238 rdf:type schema:CreativeWork
    239 sg:pub.10.1038/sj.bjc.6601383 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009220854
    240 https://doi.org/10.1038/sj.bjc.6601383
    241 rdf:type schema:CreativeWork
    242 sg:pub.10.1038/sj.bjc.6602182 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052982902
    243 https://doi.org/10.1038/sj.bjc.6602182
    244 rdf:type schema:CreativeWork
    245 sg:pub.10.1038/sj.onc.1200802 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040179514
    246 https://doi.org/10.1038/sj.onc.1200802
    247 rdf:type schema:CreativeWork
    248 sg:pub.10.1038/sj.onc.1201052 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001501834
    249 https://doi.org/10.1038/sj.onc.1201052
    250 rdf:type schema:CreativeWork
    251 sg:pub.10.1038/sj.onc.1201787 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021169319
    252 https://doi.org/10.1038/sj.onc.1201787
    253 rdf:type schema:CreativeWork
    254 sg:pub.10.1038/sj.onc.1203769 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041493903
    255 https://doi.org/10.1038/sj.onc.1203769
    256 rdf:type schema:CreativeWork
    257 sg:pub.10.1038/sj.onc.1203950 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032566096
    258 https://doi.org/10.1038/sj.onc.1203950
    259 rdf:type schema:CreativeWork
    260 sg:pub.10.1038/sj.onc.1205488 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013844073
    261 https://doi.org/10.1038/sj.onc.1205488
    262 rdf:type schema:CreativeWork
    263 sg:pub.10.1038/sj.onc.1205978 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040511970
    264 https://doi.org/10.1038/sj.onc.1205978
    265 rdf:type schema:CreativeWork
    266 sg:pub.10.1038/sj.onc.1206119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043490334
    267 https://doi.org/10.1038/sj.onc.1206119
    268 rdf:type schema:CreativeWork
    269 sg:pub.10.1038/sj.onc.1206302 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033549934
    270 https://doi.org/10.1038/sj.onc.1206302
    271 rdf:type schema:CreativeWork
    272 sg:pub.10.1038/sj.onc.1206469 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024057380
    273 https://doi.org/10.1038/sj.onc.1206469
    274 rdf:type schema:CreativeWork
    275 sg:pub.10.1038/sj.onc.1207011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028522211
    276 https://doi.org/10.1038/sj.onc.1207011
    277 rdf:type schema:CreativeWork
    278 sg:pub.10.1038/sj.onc.1208115 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019011958
    279 https://doi.org/10.1038/sj.onc.1208115
    280 rdf:type schema:CreativeWork
    281 sg:pub.10.1054/bjoc.2001.1889 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008663212
    282 https://doi.org/10.1054/bjoc.2001.1889
    283 rdf:type schema:CreativeWork
    284 sg:pub.10.1097/01.lab.0000090221.95883.41 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014386694
    285 https://doi.org/10.1097/01.lab.0000090221.95883.41
    286 rdf:type schema:CreativeWork
    287 sg:pub.10.1186/1476-4598-1-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017552858
    288 https://doi.org/10.1186/1476-4598-1-8
    289 rdf:type schema:CreativeWork
    290 grid-institutes:grid.5645.2 schema:alternateName Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Daniel den Hoed Cancer Center, Josephine Nefkens Institute, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands
    291 schema:name Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Daniel den Hoed Cancer Center, Josephine Nefkens Institute, Dr. Molewaterplein 50, 3015 GE, Rotterdam, The Netherlands
    292 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...